BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM
$310M
1-Year Est. Return
6.98%
1 Year Est. Return
+6.98%
AUM
$310M
AUM Growth
-$220K
(-0.07%)
Holding
86
Top Buys
| 1 | +$5.09M | |
| 2 | +$3.71M | |
| 3 | +$2.64M | |
| 4 |
Dell
DELL
|
+$2.56M |
| 5 |
Biomea Fusion
BMEA
|
+$2.34M |
Top Sells
| 1 | +$10M | |
| 2 | +$6.69M | |
| 3 | +$3.3M | |
| 4 |
Conduent
CNDT
|
+$3.28M |
| 5 |
Keros Therapeutics
KROS
|
+$2.71M |
Sector Composition
| 1 | Healthcare | 51.14% |
| 2 | Financials | 31.24% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Real Estate | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuveen Churchill Direct Lending
NCDL
$708M
| $65.4M | 21.11% |
4,039,553
|
|
||
2
Blue Owl Capital
OBDC
$6.66B
| $29.3M | 9.46% |
2,045,070
|
|
||
3
Cullinan Oncology
CGEM
$458M
| $18M | 5.8% |
2,385,972
-50,000
|
|
||
4
EverCommerce
EVCM
$2.14B
| $17.2M | 5.56% |
1,641,929
|
|
||
5
Tourmaline Bio
TRML
$1.23B
| $15.9M | 5.15% |
997,107
-40,000
|
|
||
6
Larimar Therapeutics
LRMR
$360M
| $14.2M | 4.6% |
4,928,040
+150,000
|
|
||
7
enGene Holdings
ENGN
$423M
| $13.6M | 4.38% |
3,728,106
+448,728
|
|
||
|
8
Conduent
CNDT
$411M
| $11.8M | 3.8% |
4,456,848
-1,240,602
|
|
||
9
Sagimet Biosciences
SGMT
$297M
| $10.1M | 3.27% |
1,328,351
|
|
||
10
Ultragenyx Pharmaceutical
RARE
$3.23B
| $9.28M | 3% |
255,238
+102,000
|
|
||
11
Holley
HLLY
$358M
| $8.22M | 2.65% |
4,112,361
-1,205,679
|
|
||
12
Civeo
CVEO
$294M
| $7.33M | 2.37% |
317,411
-30,815
|
|
||
13
Compass Therapeutics
CMPX
$681M
| $6.74M | 2.17% |
2,591,525
-363,187
|
|
||
14
Disc Medicine
IRON
$2.98B
| $6.47M | 2.09% |
122,260
-18,000
|
|
||
|
IMA
15
ImageneBio Inc
IMA
$89.5M
| $5.48M | 1.77% |
340,927
|
|
||
16
EyePoint Pharmaceuticals
EYPT
$967M
| $5.29M | 1.71% |
562,594
-235,000
|
|
||
|
TEM
17
Tempus AI
TEM
$15.5B
| $5.09M | 1.64% |
+80,167
|
|
||
18
Context Therapeutics
CNTX
$113M
| $4.85M | 1.57% |
7,407,906
+40,000
|
|
||
19
Repare Therapeutics
RPTX
$84.2M
| $4.79M | 1.54% |
3,443,659
|
|
||
20
Mineralys Therapeutics
MLYS
$3.1B
| $4.55M | 1.47% |
335,944
+129,648
|
|
||
|
CNTA
21
Centessa Pharmaceuticals
CNTA
$3.24B
| $4.34M | 1.4% |
330,600
+15,600
|
|
||
22
Tango Therapeutics
TNGX
$834M
| $4.17M | 1.35% |
814,416
-1,307,236
|
|
||
23
Eledon Pharmaceuticals
ELDN
$208M
| $3.6M | 1.16% |
1,329,912
-490,000
|
|
||
24
Pliant Therapeutics
PLRX
$111M
| $3.44M | 1.11% |
2,969,199
|
|
||
25
Aquestive Therapeutics
AQST
$827M
| $3.05M | 0.98% |
920,000
|
|